139 related articles for article (PubMed ID: 14559983)
1. Tumour angiogenesis and p53 protein expression in mammary phyllodes tumors.
Tse GM; Lui PC; Scolyer RA; Putti TC; Kung FY; Law BK; Lau TS; Lee CS
Mod Pathol; 2003 Oct; 16(10):1007-13. PubMed ID: 14559983
[TBL] [Abstract][Full Text] [Related]
2. Increased microvessel density in malignant and borderline mammary phyllodes tumours.
Tse GM; Ma TK; Chan KF; Law BK; Chen MH; Li KH; Chan EC; Mak MK
Histopathology; 2001 Jun; 38(6):567-70. PubMed ID: 11422501
[TBL] [Abstract][Full Text] [Related]
3. Increased p53 protein expression in malignant mammary phyllodes tumors.
Tse GM; Putti TC; Kung FY; Scolyer RA; Law BK; Lau TS; Lee CS
Mod Pathol; 2002 Jul; 15(7):734-40. PubMed ID: 12118111
[TBL] [Abstract][Full Text] [Related]
4. Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors.
Tse GM; Lui PC; Vong JS; Lau KM; Putti TC; Karim R; Scolyer RA; Lee CS; Yu AM; Ng DC; Tse AK; Tan PH
Breast Cancer Res Treat; 2009 Apr; 114(3):441-8. PubMed ID: 18443904
[TBL] [Abstract][Full Text] [Related]
5. Stromal expression of vascular endothelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: a multicenter study of 185 cases.
Tse GM; Lui PC; Lee CS; Kung FY; Scolyer RA; Law BK; Lau TS; Karim R; Putti TC
Hum Pathol; 2004 Sep; 35(9):1053-7. PubMed ID: 15343505
[TBL] [Abstract][Full Text] [Related]
6. Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.
Yonemori K; Hasegawa T; Shimizu C; Shibata T; Matsumoto K; Kouno T; Ando M; Katsumata N; Fujiwara Y
Pathol Res Pract; 2006; 202(10):705-12. PubMed ID: 16889904
[TBL] [Abstract][Full Text] [Related]
7. Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors.
Kuijper A; de Vos RA; Lagendijk JH; van der Wall E; van Diest PJ
Am J Clin Pathol; 2005 May; 123(5):690-8. PubMed ID: 15981808
[TBL] [Abstract][Full Text] [Related]
8. Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.
Tse GM; Wong FC; Tsang AK; Lee CS; Lui PC; Lo AW; Law BK; Scolyer RA; Karim RZ; Putti TC
J Clin Pathol; 2005 Jun; 58(6):600-4. PubMed ID: 15917410
[TBL] [Abstract][Full Text] [Related]
9. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours.
Tse GM; Chaiwun B; Lau KM; Scolyer R; Lee CS; Karim RZ; Putti TC; Law BK; Lui PC; Tan PH
J Clin Pathol; 2007 Sep; 60(9):1051-6. PubMed ID: 17158636
[TBL] [Abstract][Full Text] [Related]
11. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
Kuijper A; van der Groep P; van der Wall E; van Diest PJ
Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast.
Feakins RM; Wells CA; Young KA; Sheaff MT
Hum Pathol; 2000 Oct; 31(10):1214-22. PubMed ID: 11070114
[TBL] [Abstract][Full Text] [Related]
13. p53 protein expression and gene mutation in phyllodes tumors of the breast.
Gatalica Z; Finkelstein S; Lucio E; Tawfik O; Palazzo J; Hightower B; Eyzaguirre E
Pathol Res Pract; 2001; 197(3):183-7. PubMed ID: 11314782
[TBL] [Abstract][Full Text] [Related]
14. Correlation between P53 expression and CD34 angiogenic factor in Tunisian breast cancer.
Fourati A; Khomsi F; El May MV; Rahal K; Gamoudi A; Boussen H; Ben Abdallah M; El May A
Tunis Med; 2007 Feb; 85(2):105-8. PubMed ID: 17665654
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin expression in the epithelial components of mammary phyllodes tumors.
Tsang JY; Mendoza P; Putti TC; Karim RZ; Scolyer RA; Lee CS; Pang AL; Tse GM
Hum Pathol; 2012 Dec; 43(12):2117-23. PubMed ID: 22820000
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
[TBL] [Abstract][Full Text] [Related]
18. Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumor: a multicenter study of 143 cases.
Tse GM; Lee CS; Kung FY; Scolyer RA; Law BK; Lau TS; Putti TC
Am J Clin Pathol; 2002 Oct; 118(4):522-6. PubMed ID: 12375638
[TBL] [Abstract][Full Text] [Related]
19. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome.
Feakins RM; Mulcahy HE; Nickols CD; Wells CA
Histopathology; 1999 Aug; 35(2):162-9. PubMed ID: 10460662
[TBL] [Abstract][Full Text] [Related]
20. Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.
Tse GM; Tsang AK; Putti TC; Scolyer RA; Lui PC; Law BK; Karim RZ; Lee CS
J Clin Pathol; 2005 Feb; 58(2):185-9. PubMed ID: 15677540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]